THOMPSON SIEGEL & WALMSLEY LLC – Vertex Pharmaceuticals Incorporated Transaction History
THOMPSON SIEGEL & WALMSLEY LLC portfolio value:
$3.25M
portfolio value
THOMPSON SIEGEL & WALMSLEY LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.34% | -1.73K shares | -401K | $289.54 | 11.23K |
| Q2 2022 | share | Decrease | -37.63% | -7.82K shares | -1.77M | $281.79 | 12.96K |
| Q1 2022 | share | Decrease | -50.58% | -21.27K shares | -3.81M | $260.97 | 20.78K |
| Q4 2021 | share | Decrease | -6.74% | -3.03K shares | 1.05M | $222.45 | 42.06K |
| Q3 2021 | share | Increase | +25.07% | 9.03K shares | 910K | $181.39 | 45.10K |
| Q2 2021 | share | Increase | +2631.97% | 34.74K shares | 6.98M | $201.63 | 36.06K |
| Q1 2021 | share | Increase | +320.38% | 1.00K shares | 210K | $214.89 | 1.32K |
| Q4 2020 | share | Decrease | -11.30% | -40 shares | -22K | $236.34 | 314 |
| Q3 2020 | share | 0.00% | 0 shares | -7K | $272.12 | 354 | |
| Q2 2020 | share | 0.00% | 0 shares | 19K | $290.31 | 354 | |
| Q1 2020 | share | Decrease | -2.75% | -10 shares | 4K | $237.95 | 354 |
| Q4 2019 | share | Increase | +2.82% | 10 shares | 20K | $218.95 | 364 |
| Q3 2019 | share | 0.00% | 0 shares | -5K | $169.42 | 354 | |
| Q2 2019 | share | 0.00% | 0 shares | 0 | $183.38 | 354 | |
| Q1 2019 | share | 0.00% | 0 shares | 6K | $183.95 | 354 | |
| Q4 2018 | share | 0.00% | 0 shares | -9K | $165.71 | 354 | |
| Q3 2018 | share | 0.00% | 0 shares | 8K | $192.74 | 354 | |
| Q2 2018 | share | 0.00% | 0 shares | 2K | $169.96 | 354 | |
| Q1 2018 | share | 0.00% | 0 shares | 5K | $162.98 | 354 | |
| Q4 2017 | share | Increase | +555.56% | 300 shares | 45K | $149.86 | 354 |
| Q3 2017 | share | 0.00% | 0 shares | 1K | $152.04 | 54 | |
| Q2 2017 | share | 0.00% | 0 shares | 1K | $128.87 | 54 | |
| Q1 2017 | share | Decrease | -29.87% | -23 shares | 0 | $109.35 | 54 |
| Q4 2016 | share | Increase | +42.59% | 23 shares | 1K | $73.67 | 77 |
| Q3 2016 | share | 0.00% | 0 shares | 0 | $87.21 | 54 | |
| Q2 2016 | share | 0.00% | 0 shares | 1K | $86.02 | 54 | |
| Q1 2016 | share | 0.00% | 0 shares | -3K | $79.49 | 54 |